EIKONIZO THERAPEUTICS Trademark

Trademark Overview


On Tuesday, June 1, 2021, a trademark application was filed for EIKONIZO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EIKONIZO THERAPEUTICS trademark a serial number of 90747075. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 9, 2024. This trademark is owned by Eikonizo Therapeutics, Inc.. The EIKONIZO THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

(Based on Intent to Use) Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances or the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; dia...

(Based on Use in Commerce) Providing a website featuring information in the field of treatment for medical conditions

(Based on Use in Commerce) Research and development in the field of drug discovery, imaging agents, biotechnology and pharmaceuticals
eikonizo therapeutics

General Information


Serial Number90747075
Word MarkEIKONIZO THERAPEUTICS
Filing DateTuesday, June 1, 2021
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances or the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; diagnostic agents, preparations, substances and diagnostic materials in the form of preparations for medical purposes; imaging agents for positron emission tomography (PET) imaging for delivery of materials to target sites within the body for diagnostic purposes; imaging agents for positron emission tomography (PET) imaging for use in detecting disease, namely, radio tracers for positron emission tomography (PET) imaging
Translation of Words in MarkThe English translation of "EIKONIZO" in the mark is "ENVISAGE".
Goods and Services(Based on Use in Commerce) Providing a website featuring information in the field of treatment for medical conditions
NOT AVAILABLE"THERAPEUTICS"
Goods and Services(Based on Use in Commerce) Research and development in the field of drug discovery, imaging agents, biotechnology and pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code042
First Use Anywhere DateSunday, April 30, 2017
First Use In Commerce DateSunday, April 30, 2017

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code044
First Use Anywhere DateSunday, April 30, 2017
First Use In Commerce DateSunday, April 30, 2017

Trademark Owner History


Party NameEikonizo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameEikonizo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 15, 2022ASSIGNED TO EXAMINER
Friday, February 25, 2022NON-FINAL ACTION WRITTEN
Friday, February 25, 2022NON-FINAL ACTION E-MAILED
Friday, February 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 5, 2022ASSIGNED TO LIE
Thursday, October 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 26, 2022FINAL REFUSAL WRITTEN
Wednesday, October 26, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 26, 2022FINAL REFUSAL E-MAILED
Wednesday, April 26, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 26, 2023EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, April 26, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, April 26, 2023EX PARTE APPEAL-INSTITUTED
Thursday, April 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 11, 2024EXPARTE APPEAL TERMINATED